Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Kidney cancer, Renal cell cancer
Closed
Phase 2
This trial is looking at the effect of 2 drugs called bevacizumab and pazopanib. It is for people who have kidney cancer that has got worse despite having other treatment.
Recruitment start: 23 October 2009
Recruitment end: 30 April 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Eisen
Cambridge University Hospitals NHS Foundation Trust
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
Last reviewed: 29 April 2012
CRUK internal database number: 6049